Your browser doesn't support javascript.
loading
Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8+ T-cell Immunity.
Yin, Wenjie; Duluc, Dorothée; Joo, HyeMee; Xue, Yaming; Gu, Chao; Wang, Zhiqing; Wang, Lei; Ouedraogo, Richard; Oxford, Lance; Clark, Amelia; Parikh, Falguni; Kim-Schulze, Seunghee; Thompson-Snipes, LuAnn; Lee, Sang-Yull; Beauregard, Clay; Woo, Jung-Hee; Zurawski, Sandra; Sikora, Andrew G; Zurawski, Gerard; Oh, SangKon.
Afiliação
  • Yin W; Baylor Institute for Immunology Research, Dallas, Texas. Institute of Biomedical Studies, Baylor University, Waco, Texas.
  • Duluc D; Baylor Institute for Immunology Research, Dallas, Texas.
  • Joo H; Baylor Institute for Immunology Research, Dallas, Texas. Institute of Biomedical Studies, Baylor University, Waco, Texas.
  • Xue Y; Baylor Institute for Immunology Research, Dallas, Texas.
  • Gu C; Baylor Institute for Immunology Research, Dallas, Texas. Institute of Biomedical Studies, Baylor University, Waco, Texas.
  • Wang Z; Baylor Institute for Immunology Research, Dallas, Texas.
  • Wang L; Baylor Institute for Immunology Research, Dallas, Texas.
  • Ouedraogo R; Baylor Institute for Immunology Research, Dallas, Texas.
  • Oxford L; Division of Head and Neck Surgery, Texas Oncology, Baylor University Medical Center, Dallas, Texas.
  • Clark A; Department of Otolaryngology, Stanford School of Medicine, Palo Alto, California.
  • Parikh F; Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
  • Kim-Schulze S; Department of Medicine, Mount Sinai School of Medicine, New York, New York.
  • Thompson-Snipes L; Baylor Institute for Immunology Research, Dallas, Texas. Institute of Biomedical Studies, Baylor University, Waco, Texas.
  • Lee SY; Department of Pathology, School of Medicine, Pusan National University, Yangsan, Gyeongsangnam-do, Republic of Korea.
  • Beauregard C; Baylor Institute for Immunology Research, Dallas, Texas.
  • Woo JH; Cancer Research Institute, Baylor Scott and White Health, Temple, Texas.
  • Zurawski S; Baylor Institute for Immunology Research, Dallas, Texas.
  • Sikora AG; Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
  • Zurawski G; Baylor Institute for Immunology Research, Dallas, Texas. Institute of Biomedical Studies, Baylor University, Waco, Texas.
  • Oh S; Baylor Institute for Immunology Research, Dallas, Texas. Institute of Biomedical Studies, Baylor University, Waco, Texas. sangkono@baylorhealth.edu.
Cancer Immunol Res ; 4(10): 823-834, 2016 10.
Article em En | MEDLINE | ID: mdl-27485136
Assuntos
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Antígenos CD40 / Vacinas Anticâncer / Vacinas contra Papillomavirus / Neoplasias de Cabeça e Pescoço Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Antígenos CD40 / Vacinas Anticâncer / Vacinas contra Papillomavirus / Neoplasias de Cabeça e Pescoço Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article